Bacopa monnieri, also known as Brahmi, is a herb widely used in traditional Ayurvedic medicine, primarily as a cognitive enhancer and nervine tonic. Its use in the context of Parkinson's Disease (PD) is largely based on traditional claims regarding its general neuroprotective properties and its reputed ability to support brain function and mitigate symptoms of neurological decline. However, there is limited direct scientific evidence to substantiate its efficacy specifically for Parkinson's Disease. While some preclinical studies (in vitro and animal models) suggest that Bacopa monnieri extracts might possess antioxidant and anti-inflammatory effects, which could theoretically be beneficial in neurodegenerative conditions like PD, clinical trials in humans with Parkinson's Disease are lacking. Systematic reviews and research to date do not provide strong support for the use of Bacopa monnieri as a treatment or adjunct therapy for PD. Instead, its use in this context is primarily rooted in traditional medicine and extrapolated from its general neuroprotective effects. Therefore, while Bacopa monnieri is sometimes promoted as supportive for neurological health, there is minimal scientific validation for its use specifically for Parkinson's Disease, and it should not be considered a primary or evidence-based treatment for this condition.